About Us
Pharmaceutical Executive® provides insights and stories behind successful commercial strategies, research and development (R&D), market access and more, to its audience of pharmaceutical executives. Our original print and digital content is produced by a team of fulltime, in-house writers and industry experts, which makes us stand out from the competition.
We go beyond the 24-hour news cycle and provide in-depth analysis and the strategic context to help executives navigate the maze of policy and business challenges that face this changing industry.
Advertisement
Advertisement
Trending on PharmExec
1
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
2
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
3
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010
4
FDA Approves Utebzi for Adults with Complicated Urinary Tract Infections
5